Small biotech can soar 1,000%

Dear Fellow Investor, There's no sector poised to deliver bigger gains in 2021 than small-cap biotech stocks. In the past year alone... Novavax Inc jumped from $6.26 to $270.51, a gain of 3,396%. Aclaris Therapts jumped from $0.70 to $24.28 an increase of 1,583%. Vaxart Inc rocketed from $0.97 to $14.94, a 1,083% jump. Here's the next biotech we think could soar 1,000% >>> What drives massive gains like that? It usually comes when a biotech unveils a unique new drug. On December 5, 2020, a small Cambridge biotech shocked the world when they could "Find & Replace" the genes that cause the disease anemia. This revolutionary new kind of treatment may not just change sickle cell anemia... It has the potential to eliminate genetic disease from our species. If that sounds like science fiction, consider this... The Nobel Prize Committee is calling it "The Holy Grail of Medicine." The Wall Street Journal reports the company is "transforming medicine." 60 Minutes reports the company is "revolutionizing the search for new drugs." Here's the next biotech we think could soar 1,000% >>> Investor's Business Daily estimates the market is worth at least $75 billion. But right now, its stock price is just a tiny fraction of that size. Our research proves that anyone who gets in today could turn every $1,000 into $1.57 million (or more)! That's if the company doesn't get taken over for fast 300% gains first. CLICK HERE to see how you can profit from this unique opportunity >>> Sincerely, Dylan Jovine Chairman Behind the Markets